This invention relates to inhibitors of p38 and methods of utilizing the inhibitors and pharmaceutical compositions thereof in the treatment and prevention of various disorders mediated by p38.
本发明涉及p38抑制剂以及利用该抑制剂和药物组合物治疗和预防由p38介导的各种疾病的方法。
Medicament for treatment of liver cancer
申请人:Zender Lars
公开号:US10441577B2
公开(公告)日:2019-10-15
The invention provides a pharmaceutical composition comprising Sorafenib in combination with an inhibitor of a specific kinase inhibitor as a medicament for the treatment or prevention of liver cancer.
The invention provides a pharmaceutical composition comprising Sorafenib in combination with an inhibitor of a specific kinase inhibitor as a medicament for the treatment or prevention of liver cancer.
US8017641B2
申请人:——
公开号:US8017641B2
公开(公告)日:2011-09-13
P38 inhibitors and methods of use thereof
申请人:——
公开号:US20040192653A1
公开(公告)日:2004-09-30
This invention relates to inhibitors of p38, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders mediated by p38.